AMLX vs JPM Stock Comparison
AMLX currently leads JPM in this stock comparison, with AIQ scores of 78 vs 65. The clearest difference is momentum, while JPM has the stronger risk resilience profile.
What is the main difference between AMLX and JPM?
AMLX leads the current stock comparison as Amylyx Pharmaceuticals, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Amylyx Pharmaceuticals, Inc. vs JPMorgan Chase & Co.
AMLX leads
AMLX leads by 13 AIQ points, primarily on Momentum, and the lead has widened from 5 points over 30 sessions.
Stable: 3 of 5 evidence groups support AMLX, its lead is widening, and its signal state is cleanly positive.
Amylyx Pharmaceuticals, Inc.
JPMorgan Chase & Co.
The Algovestiq AIQ Score currently favors AMLX over JPM, 78 versus 65 as of Nov 15, 2026. AMLX's advantage is driven primarily by stronger momentum, while JPM holds the stronger risk resilience profile. AMLX also shows the stronger technical structure relative to its 50-day moving average. 3 of 5 covered evidence groups favor AMLX today, and the comparison is rated Stable on stability. AMLX lead: Strengthening — the AIQ differential moved from 5 to 13 points over 30 sessions.
Compare Amylyx Pharmaceuticals, Inc. and JPMorgan Chase & Co. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare AMLX and JPM against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Risk Resilience48 vs 87JPM +39
- Momentum90 vs 70AMLX +20
- Quality79 vs 86JPM +7
3 of 5 evidence groups favor AMLX. AMLX’s edge is concentrated in momentum; JPM keeps a meaningful risk resilience edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
No factor moved materially.
New signals
- ADX Trend Weakening — neutral, trend, medium horizon
- Accumulation Pattern — bullish, volume, medium horizon (1.14x)
- TRIX Bullish Signal — bullish, momentum, short horizon
Largest factor move: Momentum +1, not enough on its own to move the overall score.
New signals
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
AMLX's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — AMLX and JPM both carry a full feed there.
The central trade-off
AMLX (Amylyx Pharmaceuticals, Inc.): the stronger current systematic profile, led by momentum.
JPM (JPMorgan Chase & Co.): the counter-case, on risk resilience, quality.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
AMLXAMLX on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
AMLXAMLX on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
AMLXAMLX on the Momentum factor, by 20 points.
Lower downside
JPMJPM on Risk Resilience, by 39 points.
Analyst upside
AMLXAMLX on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | AMLX | JPM | Note |
|---|---|---|---|
| Implied upside to target | +58% | +7.8% | AMLX has more room |
| Target dispersion | +37.6% | +30.3% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 12 | 26 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 5 covered evidence groups favor AMLX. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | AMLX | 78 vs 65 |
| Fundamentals | Even | EPS growth 2.6% vs -27.6%; TTM ROE -6% vs 4.1% |
| Valuation | Not covered | Not covered |
| Technicals | AMLX | Price vs 50-day 2.2% vs 1.7%; vs 200-day 45.6% vs 6.6% |
| Risk Resilience | JPM | Risk Resilience 48 vs 87 |
| Analyst expectations | AMLX | Target upside 58% vs 7.8% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AMLX and JPM and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is wide at 13 points. (supports the conclusion holding)
- The leader's advantage has been widening. (supports the conclusion holding)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on AMLX.
How the comparison changed
120 daily snapshots · May 27 – Nov 13AMLX lead: Strengthening — the AIQ differential moved from 5 to 13 points over 30 sessions.
- Today
- AMLX +13
- 78 vs 65
- 7 sessions ago
- AMLX +14
- 78 vs 64
- 30 sessions ago
- AMLX +5
- 68 vs 63
- 90 sessions ago
- AMLX +3
- 67 vs 64
The lead changed hands 2 times in this window, most recently on Jul 24 when AMLX moved ahead of JPM.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
5 bullish / 0 bearish / 2 neutral
Only AMLX
- ADX Trend Weakening — neutral, trend, medium horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.43%)
- Accumulation Pattern — bullish, volume, medium horizon (1.14x)
6 bullish / 1 bearish / 1 neutral, conflicted
Only JPM
- Bollinger Band Squeeze — neutral, volatility, short horizon (5.9%)
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
- Low Volume Rally Warning — bearish, volume, short horizon (0.65x)
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
Both carry 4 more signals that do not separate them: Golden Cross Active, EMA Ribbon Expansion Bullish, TRIX Bullish Signal, Uptrend Structure Active.
JPM is conflicted, so the timing case there is weaker than the score alone suggests.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.44%, AIQ 0 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.98%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1JPM closes the Momentum gap — currently 20 points behind, the largest single contributor to AMLX's edge.
- 2JPM's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend.
- 3AMLX's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
Split| Metric | AMLX | JPM |
|---|---|---|
| Revenue growth (YoY) | 0% | -7.6% |
| EPS growth (YoY) | 2.6% | -27.6% |
| Gross margin | 0% | 63.2% |
| Operating margin | 0% | 28.2% |
| Return on equity (TTM) | -6% | 4.1% |
| Debt to equity | 0.01 | 3.32 |
Performance
AMLX leads 5 of 6 windows| Metric | AMLX | JPM |
|---|---|---|
| 1 week (5 sessions) | 2.7% | 3.5% |
| 1 month (20 sessions) | 15% | 1.9% |
| 3 months (63 sessions) | 41.3% | -4.1% |
| 6 months (126 sessions) | 128% | 16.2% |
| Year to date | 150.7% | 7.4% |
| 1 year (252 sessions) | 145.7% | 8% |
Technicals
AMLX has the stronger structure| Metric | AMLX | JPM |
|---|---|---|
| RSI (14) | 54.7 | 56.1 |
| ADX (14) | 15.9 | 18 |
| Price vs 50-day | 2.2% | 1.7% |
| Price vs 200-day | 45.6% | 6.6% |
| Volatility (1M, annualized) | 57.6% | 27.4% |
Risk
JPM is the more resilient| Metric | AMLX | JPM |
|---|---|---|
| Beta | 1.03 | 0.78 |
| Sharpe ratio | 1.35 | 0.44 |
| Sortino ratio | 3.21 | 0.61 |
| Max drawdown | -33.6% | -15.5% |
| Current drawdown | -23.6% | -5.2% |
| Annualized volatility | 87% | 22.7% |
| Value at risk (95%) | -5.5% | -2.4% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, AMLX or JPM?
On the Algovestiq AIQ Score, AMLX is the stronger of the two as of Nov 15, 2026, scoring 78 against JPM's 65. The edge comes from momentum. JPM is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is AMLX or JPM the better buy right now?
AMLX carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Stable — 3 of 5 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor AMLX over JPM?
The composite weights Quality, Value, Momentum and Risk Resilience. JPM leads Risk Resilience by 39 points; AMLX leads Momentum by 20 points; JPM leads Quality by 7 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, AMLX or JPM?
Analyst price targets imply +58% upside for AMLX and +7.8% for JPM, so the Street currently favors AMLX. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, AMLX or JPM?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, AMLX or JPM?
AMLX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, AMLX or JPM?
AMLX on the Momentum factor, by 20 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, AMLX or JPM?
JPM is the more resilient of the two, so the other name carries the higher downside risk. JPM on Risk Resilience, by 39 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is AMLX more profitable than JPM?
JPM leads on the comparable margin measures — gross margin 0% vs 63.2%; operating margin 0% vs 28.2%; ttm roe -6% vs 4.1%.
Is AMLX's lead over JPM getting stronger or weaker?
AMLX lead: Strengthening — the AIQ differential moved from 5 to 13 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 2 times in that window, most recently on 2026-07-24, when AMLX moved ahead of JPM.
What would change the AMLX vs JPM verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: JPM closes the Momentum gap — currently 20 points behind, the largest single contributor to AMLX's edge; JPM's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend; AMLX's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about AMLX and JPM?
AMLX: 5 bullish / 0 bearish / 2 neutral. JPM: 6 bullish / 1 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AMLX is Golden Cross Active (bullish, long horizon). On JPM it is Golden Cross Active (bullish, long horizon).
Compare AMLX and JPM with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.